Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review

Open Rheumatology Journal

Volumn 2, Issue , 2008, Pages 89-98

  Yuen, Sai Yan ^a   Krizova, Adriana ^a   Ouimet, Janine M ^a   Pope, Janet E ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Case control; Pregnancy outcome; Systemic lupus erythematosus (SLE)

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA; GONADORELIN ANTAGONIST; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ADULT; AMENORRHEA; ARTICLE; BLOOD CLOTTING TIME; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMORBIDITY ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; EDUCATION; EVALUATION AND FOLLOW UP; FEMALE; FERTILITY; FETUS DEATH; FIBROMYALGIA; FREQUENCY ANALYSIS; GYNECOLOGIC CARE; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYSTERECTOMY; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MIDDLE AGED; MUSCULOSKELETAL DISEASE; NEWBORN DEATH; ORAL CONTRACEPTIVE USE; OSTEOARTHRITIS; OVARY INSUFFICIENCY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY OUTCOME; PREMATURE OVARIAN FAILURE; PREMATURITY; PROLACTIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS; TENDINITIS; THERAPEUTIC ABORTION; THYROID DISEASE; VASOCONSTRICTION; YOUNG ADULT;

EID: 85056070722     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312900802010089     Document Type: Article

References (99)

1. Donaldson LB, De Alvarez RR. Further observations on lupus erythematosus associated with pregnancy. Am J Obstet Gynecol 1962; 83: 1461-73.
2. Ellis FA, Bereston ES. Lupus erythematosus associated with pregnancy and menopause. AMA Arch Derm Syphilol 1952; 65: 170-6.
3. Cervera R, Font J, Carmona F, Balasch J. Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmun Rev 2002; 1: 354-9.
4. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
5. Bae SC, Koh HK, Chang DK, Kim MH, Park JK, Kim SY. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 2001; 10: 405-9.
6. Urowitz MB, Gladman DD. Measures of disease activity and damage in SLE. Baillieres Clin Rheumatol 1998; 12: 405-13.
7. Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992; 19: 1551-8.
8. Yasmeen S, Wilkins EE, Field NT, Sheikh RA, Gilbert WM. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 2001; 10: 91-6.
9. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 2003; 30: 2127-32.
10. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002; 41: 643-50.
11. Kari JA. Pregnancy outcome in connective tissue diseases. Saudi Med J 2001; 22: 590-4.
12. Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology (Oxford) 1999; 38: 559-63.
13. Sittiwangkul S, Louthrenoo W, Vithayasai P, Sukitawut W. Pregnancy outcome in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 1999; 17: 77-83.
14. Kleinman D, Katz VL, Kuller JA. Perinatal outcomes in women with systemic lupus erythematosus. J Perinatol 1998; 18: 178-82.
15. Le Thi Huong D, Wechsler B, Piette JC, Bletry O, Godeau P. Pregnancy and its outcome in systemic lupus erythematosus. QJM 1994, 87: 721-9.
16. Tincani A, Faden D, Tarantini M, et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992; 10: 439-46.
17. Jungers P, Dougados M, Pelissier C, et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982; 142: 771-6.
18. Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980; 18: 207-20.
19. Julkunen H, Kaaja R, Palosuo T, Gronhagen-Riska C, Teramo K. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand 1993; 72: 258-63.
20. Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002; 40: 713-20.
21. Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 1993; 20 (4): 650-6.
22. Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998; 25 (8): 1526-30.
23. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med 1992; 83: 315-24.
24. Oviasu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991; 1 (1): 19-25.
25. Imbasciati E, Surian M, Bottino S, et al. Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron 1984; 36: 46-51.
26. Englert HJ, Derue GM, Loizou S, et al. Pregnancy and lupus: prognostic indicators and response to treatment. Q J Med 1988; 66: 125-36.
27. Molad Y, Borkowski T, Monselise A, et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005; 14: 145-51.
28. Aggarwal N, Sawhney H, Vasishta K, Chopra S, Bambery P. Pregnancy in patients with systemic lupus erythematosus. Aust N Z J Obstet Gynaecol 1999; 39: 28-30.
29. Johns KR, Morand EF, Littlejohn GO. Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 cases. Aust N Z J Med 1998; 28: 18-22.
30. Le Huong D, Wechsler B, Vauthier-Brouzes D, et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997; 36: 772-7.
31. Julkunen H, Jouhikainen T, Kaaja R, et al. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 1993; 2: 125-31.
32. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13: 732-9.
33. Nossent HC, Swaak TJ. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 1990; 17: 771-6.
34. Gimovsky ML, Montoro M, Paul RH. Pregnancy outcome in women with systemic lupus erythematosus. Obstet Gynecol 1984; 63: 686-92.
35. Fraga A, Mintz G, Orozco J, Orozco JH. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1974; 1: 293-98.
36. Fine L, Barnett EV, Danovitch GM, et al. Systemic lupus erythematosus in pregnancy. Ann Intern Med 1981, 94: 667-677.
37. McHugh NJ, Reilly PA, McHugh LA. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol 1989; 16: 42-6.
38. Siamopoulou-Mavridou A, Manoussakis MN, Mavridis AK, Moutsopoulos HM. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis 1988; 47: 982-7.
39. Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 2001; 60: 599-604.
40. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984; 77: 893-8.
41. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993; 36: 1392-7.
42. Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991; 151: 269-73.
43. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538-45.
44. Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996; 35: 133-8.
45. Kaufman RL, Kitridou RC. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus. J Rheumatol 1982; 9: 549-55.
46. Tozman EC, Urowitz MB, Gladman DD. Systemic lupus erythematosus and pregnancy. J Rheumatol 1980; 7: 624-32.
47. Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 192: 1897-904.
48. Mund A, Simson J, Rothfield N. Effect of pregnancy on course of systemic lupus erythematosus. JAMA 1963; 183: 917-20.
49. Rubbert A, Pirner K, Wildt L, Kalden JR, Manger B. Pregnancy course and complications in patients with systemic lupus erythematosus. Am J Reprod Immunol 1992; 28: 205-7.
50. Grigor RR, Shervington PC, Hughes GR, Hawkins DF. Outcome of pregnancy in systemic lupus erythematosus. Proc R Soc Med 1977; 70: 99-100.
51. Kiss E, Bhattoa HP, Bettembuk P, Balogh A, Szegedi G. Pregnancy in women with systemic lupus erythematosus. Eur J Obstet Gynecol Reprod Biol 2002; 101 (2): 129-34.
52. Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 2000; 39: 1014-9.
53. Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25: 184-92.
54. Jungers P, Dougados M, Pelissier C, et al. Problems posed by pregnancy in women with lupus nephropathy. Presse Med 1983; 12: 345-9.
55. Kobayashi N, Yamada H, Kishida T, et al. Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus. Am J Reprod Immunol 1999; 42: 153-9.
56. Bobrie G, Liote F, Houillier P, Grunfeld JP, Jungers P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987; 9: 339-43.
57. Wong CH, Chen TL, Lee CS, Lin CJ, Chen CP. Outcome of pregnancy in patients with systemic lupus erythematosus. Taiwan J Obstet Gynecol 2006; 45: 120-3.
58. Tan LK, Tan HK, Lee CT, Tan AS. Outcome of pregnancy in Asian women with systemic lupus erythematosus: experience of a single perinatal centre in Singapore. Ann Acad Med Singapore 2002; 31: 290-5.
59. De Bandt M, Palazzo E, Belmatoug N, et al. Outcome of pregnancies in lupus: experience at one center. Ann Med Interne (Paris) 2000; 151: 87-92.
60. Carmona F, Font J, Cervera R, Munoz F, Cararach V, Balasch J. Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999; 83: 137-42.
61. Derksen RH, Bruinse HW, de Groot PG, Kater L. Pregnancy in systemic lupus erythematosus: a prospective study. Lupus 1994; 3: 149-55.
62. Buyon J, Wallace D. The endocrine system, use of exogenous estrogens, and the urogenital tract, in Dubois' lupus erythematosus. B. Hahn, Ed., Williams & Wilkins: Baltimore, 1997, pp. 817-834.
63. Langevitz P, Klein L, Pras M, Many A. The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis. Am J Reprod Immunol 1992; 28: 157-8.
64. Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993; 119: 366-9.
65. McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 1996; 55: 224-9.
66. Mok CC, Lau CS, Wong RW. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 1998; 41: 831-7.
67. Huong DL, Amoura Z, Duhaut P, et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 2002; 29: 2571-6.
68. Ioannidis JP, Katsifis GE, Tzioufas AG, Moutsopoulos HM. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 2002; 29: 2129-35.
69. Slater CA, Liang MH, McCune JW, Christman GM, Laufer MR. Preserving ovarian function in patients receiving cyclophosphamide. Lupus 1999; 8: 3-10.
70. Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and-B as markers. Mol Cell Endocrinol 2002; 187: 93-105.
71. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 2000; 9: 401-5.
72. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR. OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353 (24): 2550-8.
73. Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, et al. Menopause hormonal therapy in women with systemic lupus erythematosus. Arthritis Rheum 2007; 56 (9): 3070-9.
74. Dhar JP, Essenmacher LM, Ager JW, Sokol RJ. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 2005; 193: 1444-55.
75. Mok MY, Leung PY, Lao TH, et al. Clinical predictors of fetal and maternal outcome in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1705-6.
76. Pierangeli SS, Harris EN. A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is? Semin Thromb Hemost 2008; 34 (4): 313-28.
77. Ramsey-Goldman R, Kutzer JE, Kuller LH, Guzick D, Carpenter AB, Medsger TA, Jr. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 1993; 138: 1057-69.
78. Khamashata M, Gil M, Pascual D. Antiphospholipid antibodies in SLE. Clinical association. Clin Exp Rheumatol 1988; 6: 205A.
79. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35 (4): 402-7.
80. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314 (7076): 253-7.
81. Erkan D, Patel S, Nuzzo M, et al. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford) 2008; 47 (Suppl 3): iii23-7.
82. Petri M, Howard D, Repke J, Goldman DW. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol 1992; 28: 188-91.
83. Johnson MJ, Petri M, Witter FR, Repke JT. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 1995; 86: 396-9.
84. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148-53.
85. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318-23.
86. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169 (6): 1411-7.
87. Lockshin MD. Lupus pregnancies and neonatal lupus. Springer Semin Immunopathol 1994; 16: 247-59.
88. Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991; 18: 349-53.
89. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994; 21: 843-50.
90. Pauzner R, Urowitz MB, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus. J Rheumatol 1994; 21: 2064-7.
91. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996; 23: 629-32.
92. Ostendorf B, Fischer R, Santen R, Schmitz-Linneweber B, Specker C, Schneider M. Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996, 25: 97-102.
93. Mok CC, Lau CS, Tam SC. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br J Rheumatol 1997; 36: 986-9.
94. Leaños-Miranda A, Cárdenas-Mondragón G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford) 2006; 45: 97-101.
95. Sugiura K, Muro Y, Watanabe A, Tomita Y. A case of systemic lupus erythematosus: continued association of circulating prolactin levels with disease activity over a 4-year follow-up period. Mod Rheumatol 2005; 15 (3): 220-2.
96. Mok CC, Wong RW, Lau CS. Exacerbation of systemic lupus erythematosus by breast feeding. Lupus 1998; 7: 569-70.
97. Weetman AP, Walport MJ. The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 1987; 26: 359-61.
98. Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 70-2.
99. Mader R, Mishail S, Adawi M, Lavi I, Luboshitzky R. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol 2007; 26 (11): 1891-4.